Your session is about to expire
← Back to Search
Cannabidiol (CBD) for Radiculopathy
Study Summary
This trial is designed to compare the effects of oral CBD to placebo in people with chronic spinal pain who are already taking opioids. It will last for two weeks, and safety and pain outcomes will be measured.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have chronic nerve pain in your back, neck or chest.The amount of pain medication you are taking will be measured using two references, one from the Centers for Medicaid and Medicare Services and another from the Centers for Disease Control and Prevention. This is to ensure safe and appropriate dosing of pain medication.
- Group 1: Cannabidiol (CBD)
- Group 2: Placebo (PCB)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open positions for this research project?
"From what is published on clinicaltrials.gov, it seems as if this trial is still looking for volunteers. The original posting was on February 3rd, 2022 with the most recent update occurring on August 25th, 2022."
Could you please share any other notable studies that have used Cannabidiol (CBD)?
"83 studies are currently underway to investigate CBD's efficacy. 18 of those studies have reached Phase 3 clinical trials. The global spread of these 311 locations running CBD trials is led by Brazil, more specifically Ribeirao Preto in Sao Paulo."
Share this study with friends
Copy Link
Messenger